• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人乳腺癌细胞中与雌激素受体加工相关的雌激素受体的动力学改变。

Kinetic alterations in estrogen receptors associated with estrogen receptor processing in human breast cancer cells.

作者信息

Strobl J S, Kasid A, Huff K K, Lippman M E

出版信息

Endocrinology. 1984 Sep;115(3):1116-24. doi: 10.1210/endo-115-3-1116.

DOI:10.1210/endo-115-3-1116
PMID:6204852
Abstract

After nuclear translocation of estrogen receptors in MCF-7 human breast cancer cells, a processing takes place resulting in a 30-70% decline in the number of estradiol-binding sites measured in nuclear extracts. We have investigated the mechanism of estrogen receptor processing and obtained evidence that multiple events are involved. We confirm, as others have shown previously, that processing involves a decrease in the amount of estradiol binding in MCF-7 cells. In addition, evidence is provided for the generation of a rapidly dissociating population of estradiol-binding sites as an early event in processing. There is a single, slowly dissociating population of estrogen binding sites when MCF-7 cells are exposed to estradiol in the presence of actinomycin D, an inhibitor of receptor processing. One hour after the addition of sufficient estradiol to induce receptor processing, an additional, more rapidly dissociating population of estrogen binding sites is detected. When cells are exposed to estradiol and ethidium bromide, a drug which shares many actions with actinomycin D, but does not inhibit receptor processing, the rapidly dissociating population of estradiol-binding sites is again observed. Significantly, the loss of estradiol-binding sites from MCF-7 cells associated with processing between 1 and 6 h of estradiol exposure, occurs exclusively from the rapidly dissociating population of sites. Whole cell equilibrium-binding assays were performed with MCF-7 cells after 30 min or 5 h of estradiol exposure to determine whether the detected changes in estradiol dissociation reflected affinity changes in a subpopulation of estrogen-binding sites. Although the number of sites detected per cell varied with the assay method employed, binding to a single saturable class of higher affinity sites is always observed. High affinity estradiol-binding sites were reduced by 45% after a 5-h incubation with estradiol in both assay methods. The loss of estradiol binding during processing may therefore be explained by the conversion of certain high affinity estrogen receptors to a rapidly dissociating form which then fails to rebind hormone, or undergoes subsequent reactions that destroy hormone binding activity. Additionally, after 6 h of exposure to estradiol, the remaining receptor-bound estradiol dissociates from intact cells with a rate increased by 50% over that seen from the slow dissociating receptors present at 1 h.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

在雌激素受体于MCF-7人乳腺癌细胞中发生核转位后,会发生一种过程,导致在核提取物中测得的雌二醇结合位点数量下降30%-70%。我们研究了雌激素受体加工的机制,并获得证据表明涉及多个事件。正如其他人先前所示,我们证实加工过程涉及MCF-7细胞中雌二醇结合量的减少。此外,有证据表明在加工的早期事件中会产生一群快速解离的雌二醇结合位点。当MCF-7细胞在放线菌素D(一种受体加工抑制剂)存在的情况下暴露于雌二醇时,存在单一的、缓慢解离的雌激素结合位点群体。在添加足够的雌二醇以诱导受体加工1小时后,检测到另外一群更快解离的雌激素结合位点。当细胞暴露于雌二醇和溴化乙锭(一种与放线菌素D有许多共同作用但不抑制受体加工的药物)时,再次观察到快速解离的雌二醇结合位点群体。值得注意的是,在雌二醇暴露1至6小时期间与加工相关的MCF-7细胞中雌二醇结合位点的丧失,仅发生在快速解离的位点群体中。在雌二醇暴露30分钟或5小时后,对MCF-7细胞进行全细胞平衡结合测定,以确定检测到的雌二醇解离变化是否反映了雌激素结合位点亚群的亲和力变化。尽管每个细胞检测到的位点数量因所采用的测定方法而异,但始终观察到与单一饱和类别的高亲和力位点的结合。在两种测定方法中,与雌二醇孵育5小时后,高亲和力雌二醇结合位点减少了45%。因此,加工过程中雌二醇结合的丧失可能是由于某些高亲和力雌激素受体转化为快速解离形式,然后无法重新结合激素,或经历破坏激素结合活性的后续反应。此外,在暴露于雌二醇6小时后,剩余的受体结合雌二醇从完整细胞中解离的速率比1小时时存在的缓慢解离受体增加了50%。(摘要截取自400字)

相似文献

1
Kinetic alterations in estrogen receptors associated with estrogen receptor processing in human breast cancer cells.人乳腺癌细胞中与雌激素受体加工相关的雌激素受体的动力学改变。
Endocrinology. 1984 Sep;115(3):1116-24. doi: 10.1210/endo-115-3-1116.
2
Estrone receptor formation during the processing of estradiol-receptor complex in MCF-7 cells.MCF-7细胞中雌二醇受体复合物加工过程中雌酮受体的形成。
Cancer Res. 1982 May;42(5):1967-74.
3
Failure of estradiol immunofluorescence in MCF-7 breast cancer cells to detect estrogen receptors.
Cancer Res. 1981 Nov;41(11 Pt 1):4644-52.
4
Biological activity and receptor binding of a strongly interacting estrogen in human breast cancer cells.一种在人乳腺癌细胞中具有强相互作用的雌激素的生物活性及受体结合情况
Cancer Res. 1984 Jun;44(6):2302-8.
5
Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.抗雌激素在MCF-7人乳腺癌细胞的抗雌激素生长抗性雌激素反应性克隆变体中的结合。
Cancer Res. 1984 Nov;44(11):5038-45.
6
Characterization of the estrogen receptor and its dynamics in MCF-7 human breast cancer cells using a covalently attaching antiestrogen.使用共价连接的抗雌激素对MCF-7人乳腺癌细胞中的雌激素受体及其动力学进行表征。
Endocrinology. 1984 Jul;115(1):143-53. doi: 10.1210/endo-115-1-143.
7
Structural requirements for high affinity ligand binding by estrogen receptors: a comparative analysis of truncated and full length estrogen receptors expressed in bacteria, yeast, and mammalian cells.
Mol Endocrinol. 1992 Jun;6(6):861-9. doi: 10.1210/mend.6.6.1495491.
8
Hormonal regulation of estrogen receptor messenger ribonucleic acid in T47Dco and MCF-7 breast cancer cells.T47Dco和MCF-7乳腺癌细胞中雌激素受体信使核糖核酸的激素调节
Mol Endocrinol. 1989 Jan;3(1):22-8. doi: 10.1210/mend-3-1-22.
9
Membrane-associated binding sites for estrogen contribute to growth regulation of human breast cancer cells.雌激素的膜相关结合位点有助于人类乳腺癌细胞的生长调节。
Oncogene. 2001 Sep 6;20(39):5420-30. doi: 10.1038/sj.onc.1204729.
10
Acceptor sites on chromatin for receptor bound by estrogen versus antiestrogen in antiestrogen-sensitive and -resistant MCF-7 cells.抗雌激素敏感和耐药的MCF-7细胞中,雌激素与抗雌激素结合的受体在染色质上的受体位点。
Endocrinology. 1986 Mar;118(3):1087-95. doi: 10.1210/endo-118-3-1087.

引用本文的文献

1
Bone endothelial cells as estrogen targets.骨内皮细胞作为雌激素作用靶点。
Calcif Tissue Int. 1993 Nov;53(5):312-7. doi: 10.1007/BF01351835.
2
Interactions between ipriflavone and the estrogen receptor.淫羊藿黄酮与雌激素受体之间的相互作用。
Calcif Tissue Int. 1995 Feb;56(2):160-5. doi: 10.1007/BF00296349.
3
Circadian rhythm of hepatic cytosolic and nuclear estrogen receptors.肝脏胞质和核雌激素受体的昼夜节律。
Chronobiol Int. 1986;3(4):207-11. doi: 10.3109/07420528609079538.
4
Early estrogen-induced metabolic changes and their inhibition by actinomycin D and cycloheximide in human breast cancer cells: 31P and 13C NMR studies.早期雌激素诱导的代谢变化及其在人乳腺癌细胞中被放线菌素D和环己酰亚胺抑制的研究:31P和13C核磁共振研究
Proc Natl Acad Sci U S A. 1989 Jul;86(14):5585-9. doi: 10.1073/pnas.86.14.5585.
5
Antiestrogenic properties of keoxifene, trans-4-hydroxytamoxifen, and ICI 164384, a new steroidal antiestrogen, in ZR-75-1 human breast cancer cells.凯昔芬、反式-4-羟基他莫昔芬以及新型甾体抗雌激素ICI 164384在ZR-75-1人乳腺癌细胞中的抗雌激素特性
Breast Cancer Res Treat. 1989 Oct;14(1):65-76. doi: 10.1007/BF01805977.